Quintrio
Home

SERVICES-MEDICAL LABORATORIES

Lumexa Imaging Holdings, Inc. Common Stock

LMRI

Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.

Last trade $14.63
Day change -$0.16 (-1.08%)
Day range $14.47 – $15.05
Volume 142,355
Market cap $1.42B

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$1.42B
Price / earnings
174.67×
Price / book
2.24×
Price / sales
1.36×
EV / sales
2.12×
EV / EBITDA
32.73×

Profitability

Earnings per share
$0.08
Return on assets
0.44%
Return on equity
1.28%
Dividend yield
0%

Liquidity and leverage

Debt / equity
1.41×
Current ratio
1.52×
Quick ratio
1.52×
Cash ratio
0.49×

Cash flow

Price / cash flow
17.25×
Price / free cash flow
35.91×
Free cash flow
$39.59M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for LMRI, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026
Revenue$271.97M$264.16M$252.54M
Cost of revenue$225.57M$225.29M$217.76M
Gross profit$46.4M$38.88M$34.78M
Selling, general and administrative$30.03M$24.4M$20.34M
Research and development$0$0$0
Total operating expenses$40.36M$34.48M$30.26M
Operating income$6.05M$4.4M$4.53M
Interest expense-$15.67M-$16.22M-$16.33M
Income before taxes$11.79M$5.77M$3.08M
Income taxes$4.61M$3.02M$1.36M
Net income$7.18M$2.75M$1.72M
Net income attributable to common shareholders$7.18M$2.75M$1.72M
EBITDA$16.38M$14.48M$14.45M
Basic earnings per share$0.07$0.03$0.02
Diluted earnings per share$0.07$0.03$0.02

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
GlobeNewswire Inc.

Lumexa Imaging Opens Three New Imaging Centers in November

Lumexa Imaging announced the opening of three new outpatient imaging centers in North Carolina, South Carolina, and Texas as part of its de novo expansion strategy. The company has added 5 new centers this year and expects to open 8-10 total in 2026, leveraging favorable market demographics and the shift from hospital-based to outpatient imaging services.

GlobeNewswire Inc.

Lumexa Imaging Expands Partnership with Advocate Health Through New Illinois Joint Venture

Lumexa Imaging announced its 10th joint venture, this time with Advocate Health to expand outpatient imaging services in Illinois. The partnership marks the company's entry into Illinois and reflects its disciplined geographic expansion strategy focused on health system partnerships and capital-efficient growth.

GlobeNewswire Inc.

Lumexa Imaging Announces Participation in Upcoming Investor Conferences

Lumexa Imaging Holdings, Inc. (Nasdaq: LMRI), a major outpatient imaging services provider, announced that CEO Caitlin Zulla and CFO Tony Martin will participate in multiple investor conferences in September 2026, including Wells Fargo, JP Morgan, Jefferies, and Deutsche Bank healthcare conferences. The company operates over 190 imaging centers with approximately 5,000 team members and conducted around 4 million procedures in 2025.

GlobeNewswire Inc.

Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer

Lumexa Imaging announced the appointment of Kyle Lynch as Chief Growth Officer to lead enterprise growth strategy through joint ventures, acquisitions, and geographic expansion. Lynch, formerly SVP of Strategy and Development at SCA Health, will oversee growth initiatives and lead the Sales Center of Excellence. The company operates over 185 outpatient imaging centers across 13 states with approximately 5,000 team members.

GlobeNewswire Inc.

Lumexa Imaging Holdings, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Johnson Fistel, PLLC is investigating potential securities fraud claims on behalf of investors in Lumexa Imaging Holdings, On Holding AG, and MillerKnoll. The investigations were prompted by significant stock price declines following financial disclosures on March 26, 2026. Investors who suffered losses are encouraged to contact the firm.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.